Both companies’ vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies conducted in Western Africa showed.
One regimen tested a dose of J&J’s vaccine, followed by a booster shot of a vaccine from Danish drug-maker Bavarian Nordic , while another tested two doses of Merck’s vaccine with eight weeks in between.“I think the study shows that both the vaccines elicit good antibody responses,” said Dr. H. Clifford Lane, one of the researchers and a clinical director at the US National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health .
The NIH researchers noted that they were unable to assess the actual level of protection against the disease from the vaccines as no participants contracted Ebola during the trial, which began enrollment in 2017. But they said the vaccines were found to be safe for children and adults.
Take a look at what's happening to the vaxxed populations on the other side. Most of Africa escaped their covid vaccine but they will never give up. These evil pharma companies are relentless 👺